Loading…

Synthesis and Structure−Activity Relationship of a New Series of COX-2 Selective Inhibitors:  1,5-Diarylimidazoles

The synthesis and the pharmacological activity of a series of 1,5-diarylimidazoles developed as potent and selective cyclooxygenase-2 (COX-2) inhibitors are described. The new compounds were evaluated both in vitro (COX-1 and COX-2 inhibition in human whole blood) and in vivo (carrageenan-induced pa...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2003-07, Vol.46 (16), p.3463-3475
Main Authors: Almansa, Carmen, Alfón, José, de Arriba, Alberto F, Cavalcanti, Fernando L, Escamilla, Ignasi, Gómez, Luis A, Miralles, Agustí, Soliva, Robert, Bartrolí, Javier, Carceller, Elena, Merlos, Manuel, García-Rafanell, Julián
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The synthesis and the pharmacological activity of a series of 1,5-diarylimidazoles developed as potent and selective cyclooxygenase-2 (COX-2) inhibitors are described. The new compounds were evaluated both in vitro (COX-1 and COX-2 inhibition in human whole blood) and in vivo (carrageenan-induced paw edema, air-pouch, and hyperalgesia tests). Modification of all the positions of two regioisomeric imidazole cores led to the identification of 4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide (UR-8880, 51f) as the best candidate, which is now undergoing Phase I clinical trials.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm030765s